Role of chest computed tomography in the diagnosis of SARS-CoV-2 pneumonia in children
https://doi.org/10.35401/2541-9897-2023-26-2-47-54
Abstract
Background: First PCR-confirmed COVID-19 cases among Russian children were reported in early March 2020. Chest computed tomography (CT) is the most sensitive imaging modality in diagnosing early signs of viral lung damage. Limited data are available on clinical and laboratory features of COVID-19 in children and on their correlation with imaging findings. Studying COVID-19 features in children is crucial for modern medicine, which makes our research relevant.
Objective: To determine the diagnostic efficacy and correlation between laboratory, clinical, and CT findings in children and adolescents with COVID-19.
Materials and methods: From February 2020 to February 2021 372 patients with suspected COVID-19 were admitted to Morozov Children’s City Clinical Hospital (Moscow, Russian Federation). This retrospective study included 158 patients who presented with positive oropharyngeal and nasopharyngeal swab results, IgM and IgG test results, changes in complete blood count, blood biochemistry and coagulation test results, clinical symptoms, and suspected SARS-CoV-2 pneumonia based on chest CT findings.
Results: Chest CT sensitivity and specificity for diagnosis of SARS-CoV-2 pneumonia were up to 98% and 85%, respectively. We considered that severe respiratory motion artifacts in young children under general anesthesia adversely affected the diagnostic efficacy. Sensitivity and specificity in this group were up to 89% and 71%, respectively.
Conclusions: Viral pneumonia signs on chest CT scans were statistically significantly more frequent in children with cough, respiratory failure signs, lymphopenia, and increased D-dimer and C-reactive protein levels. One of these signs or a combination of them are an indication for chest CT in children with suspected SARS-CoV-2 pneumonia.
About the Authors
E. S. Korochkina
Morozov Children’s City Clinical Hospital of the Moscow Healthcare Department
Russian Federation
Russian Federation
Ksenia A. Khasanova, Cand. Sci. (Med.), Radiologist, Head of the Diagnostic Radiology Unit
4 Dobryninskii pereulok, house 1/9, Moscow, 119049, Russian Federation
K. A. Khasanova
Morozov Children’s City Clinical Hospital of the Moscow Healthcare Department
Russian Federation
Russian Federation
Evgeniya S. Korochkina, Radiologist, Diagnostic Radiology Unit
Moscow
References
1. Coronavirus infection – COVID19, 10th amended version dated July 15, 2020. MedElement. Accessed August 6, 2022. (In Russ.). https://diseases.medelement.com/disease/коронавирусная%20-инфекция-2019-ncov-кп-мз-рк/16390
2. SARS-CoV-2 Variants of Concern and Variants under Investigation in England. Technical Briefing 16. Public Health England; 2021. Accessed August 16, 2022. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1001359/Variants_of_Concern_VOC_Technical_Briefing_16.pdf
3. Torjesen I. Covid-19: Delta variant is now UK’s most dominant strain and spreading through schools. BMJ. 2021;373:n1445. PMID: 34088699. https://doi.org/10.1136/bmj.n1445
4. Neuberger F, Grgic M, Diefenbacher S, et al. COVID-19 infections in day care centres in Germany: social and organisational determinants of infections in children and staff in the second and third wave of the pandemic. BMC Public Health. 2022;22(1):98. PMID: 35031025. PMCID: PMC8758891. https://doi.org/10.1186/s12889-021-12470-5
5. Roy B, Dhillon J, Habib N, Pugazhandhi B. Global variants of COVID-19: current understanding. Journal of Biomedical Sciences. 2021;8(1):8–11. https://doi.org/10.3126/jbs.v8i1.38453
6. Chauhan RS, Gabhale SD, Aga N, et al. Сinical features, differences in Covid first, second, third waves – a data base study. Turkish Journal of Physiotherapy and Rehabilitation. 2021;32(3):11397–11401.
7. Mazankova LN, Samitova ER, Osmanov IM, et al. Clinical and epidemiological features of the course of the new coronavirus infection COVID-19 in children during periods of an increase in the incidence in Moscow in 2020-20211. Children Infections. 2021;20(3):5–10. (In Russ.). https://doi.org/10.22627/2072-8107-2021-20-3-5-10
8. Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323(20):2052–2059. PMID: 32320003. PMCID: PMC7177629. https://doi.org/10.1001/jama.2020.6775
9. Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020;109:102433. PMID: 32113704. PMCID: PMC7127067. https://doi.org/10.1016/j.jaut.2020.102433
10. The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) – China, 2020. China CDC Wkly. 2020,2(8):113–122. PMID: 34594836. PMCID: PMC8392929. https://doi.org/10.46234/ccdcw2020.032
11. CDC COVID-19 Response Team. Coronavirus disease 2019 in children – United States, February 12 – April 2, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(14):422–426. PMID: 32271728. PMCID: PMC7147903. https://doi.org/10.15585/mmwr.mm6914e4
12. Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020;395(10223):470–473. PMID: 31986257. PMCID: PMC7135038. https://doi.org/10.1016/s0140-6736(20)30185-9
13. Dong Y, Mo X, Hu Y, et al. Epidemiology of COVID-19 among children in China. Pediatrics. 2020;145(6):e20200702. PMID: 32179660. https://doi.org/10.1542/peds.2020-0702
14. Kuypers J, Martin ET, Heugel J, Wright N, Morrow R, Englund JA. Clinical disease in children associated with newly described coronavirus subtypes. Pediatrics. 2007;119(1):e70–e76. PMID: 17130280. https://doi.org/10.1542/peds.2006-1406
15. Gaunt ER, Hardie A, Claas EC, Simmonds P, Templeton KE. Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method. J Clin Microbiol. 2010;48(8):2940–2947. PMID: 20554810. PMCID: PMC2916580. https://doi.org/10.1128/jcm.00636-10
16. Methodological Recommendations “Characteristics of Clinical Manifestations and Treatment of the Disease Caused by a Novel Coronavirus Infection (COVID-19) in Children”. Ministry of Health of the Russian Federation; 2020. Accessed August 16, 2022. (In Russ.). http://nasci.ru/?id=11049&download=1
17. Shekerdemian LS, Mahmood NR, Wolfe KK, et al. Characteristics and outcomes of children with coronavirus disease 2019 (COVID-19) infection admitted to US and Canadian pediatric intensive care units. JAMA Pediatr. 2020;174(9):868–873. PMID: 32392288. PMCID: PMC7489842. https://doi.org/10.1001/jamapediatrics.2020.1948
18. Wang L, Zhao L, Li F, et al. Risk assessment of venous thromboembolism and bleeding in COVID-19 patients. Clin Respir J. 2022; 16(3):182–189. PMID: 35060325. PMCID: PMC9060011. https://doi.org/10.1111/crj.13467
19. Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost. 2020;18(6):1421–1424. PMID: 32271988. PMCID: PMC7262324. https://doi.org/10.1111/jth.14830
20. Thachil J, Tang N, Gando S, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 2020;18(5):1023–1026. PMID: 32338827. https://doi.org/10.1111/jth.14810
21. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. PMID: 32171076. PMCID: PMC7270627. https://doi.org/10.1016/s0140-6736(20)30566-3
22. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844–847. PMID: 32073213. PMCID: PMC7166509. https://doi.org/10.1111/jth.14768
23. Laboratory Testing Strategy Recommendations for COVID-19: Interim Guidance, 21 March 2020. World Health Organization; 2020. Accessed August 16, 2022. https://apps.who.int/iris/bitstream/handle/10665/331509/WHO-COVID-19-lab_testing-2020.1-eng.pdf
24. Clinical Management of Severe Acute Respiratory Infection (SARI) When COVID-19 Disease is Suspected: Interim Guidance, 13 March 2020. World Health Organization; 2020. Accessed August 16, 2022. https://www.who.int/docs/default-source/coronaviruse/clinical-management-of-novel-cov.pdf
25. Gao Y, Li T, Han M, et al. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J Med Virol. 2020;92(7):791–796. PMID: 32181911. PMCID: PMC7228247. https://doi.org/10.1002/jmv.25770
26. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069. PMID: 32031570. PMCID: PMC7042881. https://doi.org/10.1001/jama.2020.1585
27. Bai HX, Hsieh B, Xiong Z, et al. Performance of radiologists in differentiating COVID-19 from non-COVID-19 viral pneumonia at chest CT. Radiology. 2020;296(2):E46–E54. PMID: 32155105. PMCID: PMC7233414. https://doi.org/10.1148/radiol.2020200823
28. He J-L, Luo L, Luo Z-D, et al. Diagnostic performance between CT and initial real-time RT-PCR for clinically suspected 2019 coronavirus disease (COVID-19) patients outside Wuhan, China. Respir Med. 2020;168:105980. PMID: 32364959. PMCID: PMC7172864. https://doi.org/10.1016/j.rmed.2020.105980
29. Caruso D, Zerunian M, Polici M, et al. Chest CT Features of COVID-19 in Rome, Italy. Radiology. 2020;296(2):E79–E85. PMID: 32243238. PMCID: PMC7194020. https://doi.org/10.1148/radiol.2020201237
Review
For citations:
Korochkina E.S., Khasanova K.A. Role of chest computed tomography in the diagnosis of SARS-CoV-2 pneumonia in children. Innovative Medicine of Kuban. 2023;(2):47-54. (In Russ.) https://doi.org/10.35401/2541-9897-2023-26-2-47-54
Views:
299
Email this article 
